Pasar al contenido principal

Hacia una Medicina de Precisión: Análisis del Exposoma y Omicas usando Inteligencia Artificial Explicable para estudiar su impacto durante la vida en la Obesidad, Insulino Resistencia y salud metabólica EXOMAIR

PI23/00165

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i en Salud
Año convocatoria 2023
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION PUBLICA GALEGA INSTITUTO DE INVESTIGACION SANITARIA DE SANTIAGO DE COMPOSTELA
Centro realización INSTITUTO DE INVESTIGACION SANITARIA DE SANTIAGO DE COMPOSTELA (IDIS)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Contribución de congreso (ConferenceOutput)

Leveraging Machine Learning and Genetic Risk Scores for the Prediction of Metabolic Syndrome in Children with Obesity

  • Aguilera, Concepción M.
  • Bustos-Aibar, Mireia
  • Anguita-Ruiz, Augusto
  • Torres-Martos, Álvaro
  • Bueno, Gloria
  • Leis, Rosaura
  • Alcalá-Fernández, Jesús
Background and objectives: Obesity is a growing global epidemic, associated with increased cardiometabolic disorders. Metabolic syndrome (MS) is defined by altered insulin, blood pressure, glucose, and lipid levels. Pubertal children with obesity are highly susceptible to developing MS, necessitating its early identification. This study aims to compute phenotype-specific genetic risk scores for MS-related biochemical markers and evaluate their clinical utility using machine learning- based models. Methods: Longitudinal data from the PUBMEP Spanish cohort were analyzed, including 138 children (71 girls and 67 boys) at two time points, spanning from prepuberty to puberty. Clinical, endogenous, environmental, and omics variables were measured. Genetic risk scores were generated using GWAS data and PRSice-2 software. These scores, alongside non-genetic prepubertal data (e.g., biochemical, anthropometric, and physical activity data), were integrated into predictive models using machine learning techniques to forecast the MS status during puberty. Linear models explored interactions between environmental factors, genetic risk scores, and disease risk. Results: Strong associations were observed between each genetic risk score and its corresponding phenotypic biomarker. Notably, certain scores related to obesity and high-density lipoprotein levels exhibited significant interactions with environmental factors, such as sedentary lifestyle, modulating disease effects. The predictive machine learning models incorporating prepubertal genetics, high- density lipoprotein, and sedentary lifestyle achieved reasonable performance in predicting pubertal obesity (AUC, accuracy, and sensitivity of 0.89). These models strike a favorable balance between risk scores derived from genetic factors and clinical variables. However, when individual risk scores were considered in isolation, limited predictive results were observed for MS and associated altered components. Discussion: This study demonstrates the importance of the early identification of at-risk children for MS. The integration of genetic risk scores, clinical variables, and machine learning techniques offers promising avenues for predicting pubertal MS. While individual risk scores have limitations in isolation, polygenic risk scores serve as valuable tools for investigating gene– environment interactions. Following our results, polygenic risk scores lacked sufficient predictive ability in most clinical traits, limiting their clinical application. Nevertheless, they remain valuable analytical tools for exploring the association with the environment, by consolidating the effects of multiple single nucleotide polymorphisms into a single variable.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Multiomics and eXplainable artificial intelligence for decision support in insulin resistance early diagnosis: a pediatric population-based longitudinal study

  • Torres-Martos, Álvaro
  • Anguita-Ruiz, Augusto
  • Bustos-Aibar, Mireia
  • Ramírez-Mena, Alberto
  • Arteaga, María
  • Bueno, Gloria
  • Leis, Rosaura
  • Aguilera, Concepción M.
  • Alcalá, Rafael
  • Alcalá-Fdez, Jesús
Pediatric obesity can drastically heighten the risk of cardiometabolic alterations later in life, with insulin resistance standing as the cornerstone linking adiposity to the increased cardiovascular risk. Puberty has been pointed out as a critical stage after which obesity-associated insulin resistance is more difficult to revert. Timely prediction of insulin resistance in pediatric obesity is therefore vital for mitigating the risk of its associated comorbidities. The construction of effective and robust predictive systems for a complex health outcome like insulin resistance during the early stages of life demands the adoption of longitudinal designs for more causal inferences, and the integration of factors of varying nature involved in its onset. In this work, we propose an eXplainable Artificial Intelligence-based decision support pipeline for early diagnosis of insulin resistance in a longitudinal cohort of 90 children. For that, we leverage multi-omics (genomics and epigenomics) and clinical data from the pre-pubertal stage. Different data layers combinations, pre-processing techniques (missing values, feature selection, class imbalance, etc.), algorithms, training procedures were considered following good practices for Machine Learning. SHapley Additive exPlanations were provided for specialists to understand both the decision-making mechanisms of the system and the impact of the features on each automatic decision, an essential issue in high-risk areas such as this one where system decisions may affect people’s lives. The system showed a relevant predictive ability (AUC and G-mean of 0.92). A deep exploration, both at the global and the local level, revealed promising biomarkers of insulin resistance in our population, highlighting classical markers, such as Body Mass Index z-score or leptin/adiponectin ratio, and novel ones such as methylation patterns of relevant genes, such as HDAC4, PTPRN2, MATN2, RASGRF1 and EBF1. Our findings highlight the importance of integrating multi-omics data and following eXplainable Artificial Intelligence trends when building decision support systems.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

ObMetrics: A Shiny app to assist in metabolic syndrome assessment in paediatric obesity

  • Torres-Martos, Álvaro
  • Requena, Francisco
  • López-Rodríguez, Guadalupe
  • Hernández-Cabrera, Jhazmin
  • Galván, Marcos
  • Solís-Pérez, Elizabeth
  • Romo-Tello, Susana
  • Jasso-Medrano, José Luis
  • Vilchis-Gil, Jenny
  • Klünder-Klünder, Miguel
  • Martínez-Andrade, Gloria
  • Enríquez, María Elena Acosta
  • Aristizabal, Juan Carlos
  • Ramírez-Mena, Alberto
  • Stratakis, Nikos
  • Bustos-Aibar, Mireia
  • Gil, Ángel
  • Gil-Campos, Mercedes
  • Bueno, Gloria
  • Leis, Rosaura
  • Alcalá-Fdez, Jesús
  • Aguilera, Concepción María
  • Anguita-Ruiz, Augusto
SummaryObjectiveTo introduce ObMetrics, a free and user‐friendly Shiny app that simplifies the calculation, data analysis, and interpretation of Metabolic Syndrome (MetS) outcomes according to multiple definitions in epidemiological studies of paediatric populations. We illustrate its usefulness using ethnically different populations in a comparative study of prevalence across cohorts and definitions.MethodsWe conducted a case study using data from two ethnically diverse paediatric populations: a Hispanic‐American cohort (N = 1759) and a Hispanic‐European cohort (N = 2411). Using ObMetrics, we computed MetS classifications (Cook, Zimmet, Ahrens) and component‐specific z‐scores for each participant to compare prevalences.ResultsThe analysis revealed significant heterogeneity in MetS prevalence across different definitions and cohorts. According to Cook, Zimmet, and Ahrens's definitions, MetS prevalence in children with obesity was 25%, 12%, and 48%, respectively, in the Hispanic‐European cohort, and 38%, 27%, and 66% in the Hispanic‐American cohort. Calculating component‐specific z‐scores in each cohort also highlighted ethnic‐specific differences in lipid metabolism and blood pressure. By automating these complex calculations, ObMetrics considerably reduced analysis time and minimised the potential for errors.ConclusionObMetrics proved to be a powerful tool for paediatric research, generating detailed reports on the prevalence of MetS and its components based on various definitions and reference standards. Our case study further provides valuable insights into the challenges of characterising metabolic health in paediatric populations. Future efforts should focus on developing unified consensus guidelines for paediatric MetS. Meanwhile, ObMetrics enables earlier identification and targeted intervention for high‐risk children and adolescents.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Novel epigenetic marks of insulin resistance trajectories in a longitudinal study of childhood obesity

  • Anguita-Ruiz, Augusto
  • Torres-Martos, Álvaro
  • Bustos-Aibar, Mireia
  • Setó-Llorens, Adrià
  • Ruiz-Ojeda, Francisco Javier
  • Moreno, Luis A.
  • Gil, Ángel
  • Gil-Campos, Mercedes
  • Bueno, Gloria
  • Leis, Rosaura
  • Alcalá-Fdez, Jesús
  • Aguilera, Concepción M.
Background Childhood obesity is a major global public-health challenge. Insulin resistance (IR) is a critical driver of later cardiometabolic alterations. A comprehensive understanding of the molecular mechanisms underlying the initial development of childhood IR is essential for timely prevention and intervention. In this study, we aimed to assess the association between IR and blood DNA methylation in a longitudinal study from childhood into adolescence. Methods The PUBMEP study included a longitudinal core of 90 children with paired blood samples collected at both pre-pubertal and pubertal stages. For cross-sectional analyses, this sample was expanded to 99 pre-pubertal and 129 pubertal participants. IR status was defined according to clinically relevant sex- and pubertal stage specific HOMA-IR cut-offs, as recommended by pediatric expert clinicians. Genotype data was obtained with the Infinium Global Screening Array, and blood DNA methylation sites with the Infinium MethylationEPIC BeadChip. Epigenome-wide associations with IR status and trajectories were tested using linear models in the longitudinal and cross-sectional sets. FDR-adjusted significant CpG sites were assessed with sex- and age-standardised cardiometabolic z-scores (adiposity, lipids, blood pressure, glycaemia and IR) at each stage. mQTL analyses were performed to identify genetic variants that drive IR-associated methylation signals. Results We identified 120 CpG sites related to obesity-associated IR in the context of pubertal transition that remained significant after global FDR correction (FDR < 0.05). These CpG sites showed distinct methylation profiles that tracked IR trajectories from prepuberty to puberty, with consistent differences across children whose IR improved, worsened or remained stable, with several of them also related to cardiometabolic traits at pubertal stage, including adiposity measures, blood pressure and glycaemic indices. Among the FDR-significant CpG sites with biological relevance for IR, methylation at CpG sites annotated to SLC2A9, PEPD, TSC2, EGLN3, EHD2 and VASN showed consistent associations with pubertal HOMA-IR z-score and, for several loci, with adiposity and blood pressure measures, with methylation changes paralleling IR worsening, improvement or stability across puberty. An mQTL look-up in GoDMC identified 25 cis SNP CpG associations corresponding to 20 of the 120 CpG sites, including CpG sites in SLC2A9 and TSC2, indicating that only a fraction of these IR-associated CpG sites is likely to be partly influenced by nearby genetic variants. Conclusion This longitudinal EWAS in children with obesity shows that specific blood DNA methylation signatures mirror IR status and track its evolution across the pubertal transition, with opposing methylation trajectories distinguishing improving from persistent IR. The identification of CpG sites at VASN, SLC2A9, PEPD, EGLN3, EHD2 and TSC2 links IR trajectories to pathways involved in vascular signalling, urate transport, extracellular matrix remodelling, and hypoxia sensing and nutrient signalling. Complementary mQTL analyses suggest that while some of this epigenetic variation is influenced by local genetic factors, a substantial component is likely acquired in response to metabolic and external exposures. If replicated and functionally characterised, these findings may help refine our understanding of the early molecular architecture of obesity-related IR and inform future strategies for cardiometabolic risk assessment and timing of preventive interventions.